Long-Term Assets: The sum of all assets classified as non-current.
AC Immune (ACIU) had Long-Term Assets of $73.21M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
$1.43M |
|
$-18.89M |
|
-- |
|
$1.43M |
|
$20.30M |
|
$-18.87M |
|
$-0.02M |
|
$-18.89M |
|
$-18.89M |
|
$-18.89M |
|
$-18.89M |
|
$-18.89M |
|
$-18.89M |
|
$-18.87M |
|
-- |
|
98.67M |
|
98.67M |
|
$-0.19 |
|
$-0.19 |
|
| Balance Sheet Financials | |
$102.16M |
|
$2.62M |
|
|
Long-Term Assets |
$73.21M |
$175.36M |
|
$117.72M |
|
$4.44M |
|
$17.40M |
|
$135.12M |
|
$40.24M |
|
$-24.10M |
|
$40.24M |
|
-- |
|
| Cash Flow Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|